compare the effectiveness of hyperproteic hypocaloric feeding plan with normoproteic on body composition biochemical parameters and inflammatory cytokin in obese pre bariatric surgery patients in the integral treatment hyperproteic hypocaloric diet do not show advantages in weight reduction and body fat or in muscle mass gain compared to the normoproteic hypocaloric diet in patients with morbid obesity bariatric pre surgery in the integral treatment dieta hipocalorico hiperproteico mostrar ventaja reduccion peso grasa corporal ganancia masa muscular comparacion dieta hipocalorico normoproteico paciente obesidad morbido precirugia bariatrico sometido tratamiento integral comparar efectividad plan alimentacion hipocalorico hiperproteico normoproteico composicion corporal parametro bioquimico citocina inflamatoria paciente obeso precirugia bariatrico sometido tratamiento integral ambos grupo observar disminucion peso imc masa grasa asi incremento masa muscular respecto momento basal p 0 05 diferencia grupo estudiado encontrar cambio parametro bioquimico concentracion serica factor necrosis tumoral tnf interleucina il 6 despues 4 mes tratamiento grupo evaluado p 0 05 concentracion serica il 1β disminuir unicamente dieta hipocalorico normoproteico p 0 02 in both groups studiedir decrease in weight bmi and fat mass was observed as well as an increar in muscle mass compared to baseline p 0 05 differenz showed between the groups studiedir changir was found in the biochemical parameters and serum levels of tnf and il 6 before and after 4 months of treatment nor among the groups evaluated p 0 05 serum il 1β levels decreased after treatment with only normoprotein hypocaloric diet p 0 02 ­ seventy six pre bariatric surgery patients with body mass index bmi ≥ 40 kg m² were studied one group was treated with hyperproteic hypocaloric diet and compared with normoproteic hypocaloric diet biochemical parameters anthropometric parameters body composition and levels of tumor necrosis factor tnf interleukin il 6 and il 1β in serum were evaluated at the initiation of treatment and after 4 months estudiar 76 paciente indice masa corporal imc ≥ 40 kg m² previamente cirugia bariatrico grupo ser tratar dieta hipocalorico hiperproteico comparar dieta hipocalorico normoproteico evaluar parametro bioquimico parametro antropometrico composicion corporal valor citocina inflamatoria suero inicio despues 4 mes tratamiento